The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma - Implications on the T-classification system

Journal of Surgical Oncology

Volumn 110, Issue 7, 2014, Pages 876-882

  Brougham, Nicholas D L ^a,b   Tan, Swee T ^a,b  

^a GILLIES MCINDOE RESEARCH INSTITUTE   (New Zealand)

^b Wellington Regional Plastic   (New Zealand)

Author keywords

cutaneous; incidence; metastasis; risk factors; squamous cell carcinoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; DISEASE DURATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH VESSEL METASTASIS; METASTASIS; METASTASIS INCIDENCE; METASTASIS RISK; PERINEURAL INVASION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCAR FORMATION; SEX; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; THICKNESS; TUMOR DIFFERENTIATION; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; EPIDEMIOLOGY; INCIDENCE; NEW ZEALAND; PATHOLOGY; PROGNOSIS; RISK FACTOR; SECONDARY; SKIN NEOPLASMS; STANDARDS;

CARCINOMA, SQUAMOUS CELL; HUMANS; INCIDENCE; NEOPLASM STAGING; NEW ZEALAND; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS;

EID: 84922278205     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23731     Document Type: Review

References (83)

1. Staples MP, Elwood M, Burton RC, et al.,: Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
2. Halder RM, Bridgeman-Shah S,: Skin cancer in African Americans. Cancer 1995; 75: 667-673.
3. Gloster HM Jr, Neal K,: Skin cancer in skin of color. J Am Acad Dermatol 2006; 55: 741-760 quiz 761-744.
4. Ashby MA, Smith J, Ainslie J, McEwan L,: Treatment of nonmelanoma skin cancer at a large Australian center. Cancer 1989; 63: 1863-1871.
5. Brougham NDL, Tan ST, Dennett ER,: Changing incidence of non-melanoma skin cancer in New Zealand ANZ J Surg 2011; 81: 633-636.
6. Gray DT, Suman VJ, Su WP, et al.,: Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997; 133: 735-740.
7. Green A, Williams G, Neale R, et al.,: Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. [see comment][erratum appears in Lancet 1999, 18;354(9183):1038]. Lancet 1999; 354: 723-729.
8. Brougham NDL, Dennett ER, Tan ST,: Non-melanoma skin cancers in New Zealand-a neglected problem. N Z Med J 2010; 123: 59-65.
9. Buettner PG, Raasch BA,: Incidence rates of skin cancer in Townsville, Australia. [erratum appears in Int J Cancer 2001, 15;93:302-3]. Int J Cancer 1998; 78: 587-593.
10. Brunner M, Veness MJ, Ch'ng S, et al.,: Distant metastases from cutaneous squamous cell carcinoma-analysis of AJCC stage IV. Head Neck 2013; 35: 72-75.
11. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In:, Edge SB, Byrd DR, Compton CC, et al.: (eds): AJCC cancer staging manual. New York: Springer 2010.
12. Farasat S, Yu SS, Neel VA, et al.,: A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051-1059.
13. Brantsch KD, Meisner C, Schonfisch B, et al.,: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720.
14. Brougham NDL, Dennett ER, Cameron R, Tan ST,: The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106: 811-815.
15. Rowe DE, Carroll RJ, Day CL Jr:, Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.[see comment]. J Am Acad Dermatol 1992; 26: 976-990.
16. Durkovsky J, Krajci M, Michalikova B,: To the problem of the lip cancer metastases. Neoplasma 1972; 19: 653-659.
17. Epstein E, Epstein NN, Bragg K, Linden G,: Metastases from squamous cell carcinomas of the skin. Arch Dermatol 1968; 97: 245-251.
18. Lund HZ,: How often does squamous cell carcinoma of the skin metastasize ? Arch Dermatol 1965; 92: 635-637.
19. Katz AD, Urbach F, Lilienfeld AM,: The frequency and risk of metastases in squamous-cell carcinoma of the skin. Cancer 1957; 10: 1162-1166.
20. Dinehart SM, Pollack SV,: Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989; 21: 241-248.
21. Tavin E, Persky M,: Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996; 106: 156-158.
22. Chuang TY, Popescu NA, Su WP, Chute CG,: Squamous cell carcinoma. A population-based incidence study in Rochester. Minn Arch Dermatol 1990; 126: 185-188.
23. Leibovitch I, Huilgol SC, Selva D, et al.,: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005; 53: 261-266.
24. Mohs FE, Lathrop TG,: Modes of spread of cancer of skin. AMA Arch Derm Syphilol 1952; 66: 427-439.
25. Goepfert H, Dichtel WJ, Medina JE, et al.,: Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148: 542-547.
26. Feasel AM, Brown TJ, Bogle MA, et al.,: Perineural invasion of cutaneous malignancies. Dermatol Surg 2001; 27: 531-542.
27. Clayman GL, Lee JJ, Holsinger FC, et al.,: Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765.
28. McCord MW, Mendenhall WM, Parsons JT, et al.,: Skin cancer of the head and neck with clinical perineural invasion. Int J Radiat Oncol Biol Phys 2000; 47: 89-93.
29. McCord MW, Mendenhall WM, Parsons JT, Flowers FP,: Skin cancer of the head and neck with incidental microscopic perineural invasion. Int J Radiat Oncol Biol Phys 1999; 43: 591-595.
30. Carter JB, Johnson MM, Chua TL, et al.,: Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol 2013; 149: 35-41.
31. Moore BA, Weber RS, Prieto V, et al.,: Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567.
32. Ebrahimi A, Clark JR, Ahmadi N, et al.,: Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases. Head Neck 2012.
33. Breuninger H, Black B, Rassner G,: Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94: 624-627.
34. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP,: Desmoplastic squamous cell carcinoma of skin and vermilion surface: A highly malignant subtype of skin cancer. Cancer 1997; 79: 915-919.
35. Petter G, Haustein UF,: Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26: 521-530.
36. Frierson HF Jr, Cooper PH,: Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 1986; 17: 346-354.
37. Mohs FE,: Chemosurgery: microscopically controlled surgery for skin cancer-past, present and future. J Dermatol Surg Oncol 1978; 4: 41-54.
38. Cassarino DS, Derienzo DP, Barr RJ,: Cutaneous squamous cell carcinoma: A comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006; 33: 191-206.
39. Sims CF, Kirsch N,: Spindle cell epidermoid epithelioma simulating sarcoma in chronic radiodermatitis. Arch Derm Syphilol 1948; 57: 63-68.
40. Mitsuhashi T, Itoh T, Shimizu Y, et al.,: Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants. J Cutan Pathol 2006; 33: 246-252.
41. Brown MD, Swanson NA,: Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989; 15: 1287-1292.
42. Martin HE, Stewart FW,: Spindle-Cell Epidermoid Carcinoma. Am J Cancer 1935; 2: 273-298.
43. Silvis NG, Swanson PE, Manivel JC, et al.,: Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas ". Am J Dermatopathol 1988; 10: 9-19.
44. Evans HL, Smith JL,: Spindle cell squamous carcinomas and sarcoma-like tumors of the skin: A comparative study of 38 cases. Cancer 1980; 45: 2687-2697.
45. Strauss MJ,: Spindle cell epidermoid carcinoma: Report of five cases in patients who had never been exposed to roentgen rays. Arch Derm Syphilol 1950; 61: 633-647.
46. Boyd AS, Stasko TS, Tang YW,: Basaloid squamous cell carcinoma of the skin. J Am Acad Dermatol 2011; 64: 144-151.
47. De Stefano A, Dispenza F, Petrucci AG, et al.,: Features of biopsy in diagnosis of metatypical basal cell carcinoma (Basosquamous Carcinoma) of head and neck. Otolaryngol Pol 2012; 66: 419-423.
48. Cubilla AL, Reuter VE, Gregoire L, et al.,: Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol 1998; 22: 755-761.
49. Afzelius LE, Gunnarsson M, Nordgren H,: Guidelines for prophylactic radical lymph node dissection in cases of carcinoma of the external ear. Head Neck 1980; 2: 361-365.
50. Dean AL,: Epithelioma of scrotum. J Urol 1948; 60: 508-518.
51. Staubitz WJ, Lent MH, Oberkircher OJ,: Carcinoma of the penis. Cancer 1955; 8: 371-378.
52. Lewis KG, Weinstock MA,: Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004; 140: 837-842.
53. Rayner CR,: The results of treatment of two hundred and seventy-three carcinomas of the hand. Hand 1981; 13: 183-186.
54. Carucci JA, Martinez JC, Zeitouni NC, et al.,: In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30: 651-655.
55. Dinehart SM, Peterson S,: Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005; 31: 1379-1384.
56. Friedman HI, Cooper PH, Wanebo HJ,: Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985; 56: 1099-1105.
57. Dinehart SM, Nelson-Adesokan P, Cockerell C, et al.,: Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997; 79: 920-923.
58. Veness MJ, Palme CE, Morgan GJ,: High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389-2396.
59. Mullen JT, Feng L, Xing Y, et al.,: Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006; 13: 902-909.
60. Renzi C, Mastroeni S, Mannooranparampil TJ, et al.,: Delay in diagnosis and treatment of squamous cell carcinoma of the skin. Acta Derm Venereol 2010; 90: 595-601.
61. Jensen P, Hansen S, Moller B, et al.,: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-186.
62. Boffetta P, Gridley G, Lindelof B,: Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117: 1531-1537.
63. Veness MJ, Quinn DI, Ong CS, et al.,: Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-1764.
64. Dantal J, Hourmant M, Cantarovich D, et al.,: Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623-628.
65. Smith KJ, Hamza S, Skelton H,: Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30: 634-641.
66. Martinez JC, Otley CC, Stasko T, et al.,: Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139: 301-306.
67. Veness MJ, Porceddu S, Palme CE, Morgan GJ,: Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631.
68. Kovach BT, Stasko T,: Skin cancer after transplantation. Transplant Rev (Orlando) 2009; 23: 178-189.
69. Novick M, Gard DA, Hardy SB, Spira M,: Burn scar carcinoma: a review and analysis of 46 cases. J Trauma 1977; 17: 809-817.
70. Ames FC, Hickey RC,: Squamous cell carcinoma of the skin of the extremities. Int Adv Surg Oncol 1980; 3: 179-199.
71. Stromberg BV, Keiter JE, Wray RC, Weeks PM,: Scar carcinoma: prognosis and treatment. South Med J 1977; 70: 821-822.
72. Visuthikosol V, Boonpucknavig V, Nitiyanant P,: Squamous carcinoma in scars: clinicopathological correlations. Ann Plast Surg 1986; 16: 42-48.
73. Pekarek B, Buck S, Osher L,: A Comprehensive Review on Marjolin's Ulcers: Diagnosis and Treatment. J Am Col Certif Wound Spec 2011; 3: 60-64.
74. Buethe D, Warner C, Miedler J, Cockerell CJ,: Focus Issue on Squamous Cell Carcinoma: Practical Concerns Regarding the 7th Edition AJCC Staging Guidelines. J Skin Cancer 2011; 2011: 156391.
75. Warner CL, Cockerell CJ,: The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011; 12: 147-154.
76. Andruchow JL, Veness MJ, Morgan GJ, et al.,: Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006; 106: 1078-1083.
77. Stefoski Mikeljevic J, Johnston C, Adamson PJ, et al.,: How complete has skin cancer registration been in the UK? A study from Yorkshire. Eur J Cancer Prev 2003; 12: 125-133.
78. Motley R, Kersey P, Lawrence C, et al.,: Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003; 56: 85-91.
79. Basal cell carcinoma, squamous cell carcinoma (and related lesions)-a guide to clinical management in Australia Sydney: Cancer Council Australia and Australian Cancer Network; 2008.
80. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al.,: Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol 2013; 149: 402-410.
81. Renzi C, Caggiati A, Mannooranparampil TJ, et al.,: Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007; 33: 364-369.
82. Ross AS, Schmults CD,: Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature. Dermatol Surg 2006; 32: 1309-1321.
83. Rastrelli M, Soteldo J, Zonta M, et al.,: Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result. Eur Surg Res 2010; 44: 204-208.